Qiagen, a Dutch listed company, is the world's leading supplier of sample preparation and analysis technology. Sample preparation technology is used to separate and process DNA, RNA and proteins extracted from blood or tissue samples, and analysis technology makes these separated molecules detectable for biological research and disease detection. Qiagen has developed more than 500 comprehensive product portfolios, including reagents and automation solutions. Qiagen's main customers include molecular diagnostic laboratories, academic research fields, pharmaceutical and biotechnology companies, and application testing users (such as forensic identification, animal and food testing, and drug process control).
Qiagen's analytical technology covers the widest range of molecular diagnostic products, including HPV detection reagents known as the "gold standard" in the detection of high-risk HPV, the main etiology of cervical cancer, and supporting reagents widely used in infectious diseases and concomitant diagnosis. As of December 31, 2011, Qiagen has more than 3900 employees in more than 35 cities around the world.
Qiagen is a multinational enterprise specializing in biomolecular sample preparation solutions, headquartered in Germany. Qiagen was founded in Germany in 1984 and listed on NASDAQ in New York in 1996. Qiagen has four regional headquarters in Asia Pacific, Japan, North America and Europe, 19 branches, nearly 2000 employees, more than 500 products, more than 400000 users, 409 approved patents and more than 300 patents under application. Since its establishment for more than 20 years, Qiagen has developed rapidly and achieved good performance. In recent 10 years, the average annual sales growth is 25% and the average profit growth is about 33%. Qiagen's sales reached US $400 million in 2005, US $450 million in 2006 and US $520 million in 2007. Qiagen is an industry giant in the fields of life science research, applied testing and clinical diagnosis.
Qiagen has more than 1000 patents and recognition certificates, has set up branches in 18 countries, has more than 40 agent service countries, and has more than 400000 users worldwide. Qiagen provides more than 500 kinds of products, including various reagents, consumables and automatic purification workstations. These products are used in sample collection, stabilization, separation, purification and detection of nucleic acid or protein. They are not only widely used in all aspects of scientific research, but also widely used in biotechnology, pharmacy, forensic research, food safety detection, animal husbandry and molecular diagnosis. Qiagen's excellent quality and excellent performance in application make us synonymous with the standard in sample processing.